Flow Neuroscience Introduces FDA-Approved At-Home Depression Treatment in US

Flow Neuroscience has launched FL-100, the first FDA-approved at-home transcranial direct current stimulation (tDCS) treatment for moderate to severe major depressive disorder in adults. Available by prescription, this device offers a new evidence-based therapy option, either alone or with medication, potentially expanding access to depression management for patients and clinicians across the United States.